Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Feb 26, 2025 · 10-K · 57 days after period end · 0000950170-25-027756
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | $253.00K | $567.00K |
| Net Income | -$76.00M | -$83.50M | -$67.50M | -$67.46M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d after period end
